Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

ORTHOTOPIC LIVER-TRANSPLANTATION FOR ACUTE AND SUBACUTE HEPATIC-FAILURE IN ADULTS HEPATOLOGY Peleman, R. R., GAVALER, J. S., VANTHIEL, D. H., Esquivel, C., Gordon, R., Iwatsuki, S., Starzl, T. E. 1987; 7 (3): 484-489

Abstract

The role of liver transplantation in 29 patients with fulminant and subacute hepatic failure due to a variety of different causes was examined by comparing the outcome and a variety of "hospitalization" variables. Transplanted patients (n = 13) were more likely to survive (p less than 0.05), were younger (p less than 0.05) and spent more time in the hospital (p less than 0.025) than did those who were not transplanted (n = 16). Despite spending a much longer time in the hospital, transplanted patients spent less time in the intensive care unit (p less than 0.05) in coma (p less than 0.01) and on a respirator (p less than 0.01) than did those not transplanted. Most importantly, the survival rate for transplanted patients was significantly improved (p less than 0.05) as compared to those not transplanted. We conclude that liver transplantation can be applied successfully to the difficult clinical problem of fulminant and subacute hepatic failure.

View details for Web of Science ID A1987H406200011

View details for PubMedID 3552924

View details for PubMedCentralID PMC3032406